We created the RID 450: Orphan Drug Voluntary Discount Removal Impact report in response to the manufacturer, Amgen, discontinuing voluntary 340B-like discounts on their orphan drugs starting January 1, 2021.
This standard report will be available for users with Hospital Administrator access in 340B Architect. When this report is generated, it will show how many 340B accumulations are available by PID for all NDCs affected by the notice.
Hospital Reports